FibroBiologics OverviewLatest common stock for FBLG: $1K.
Get informed when a big investor buys or sells
+ Follow
Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
The latest common stock for FBLG is $1K as of June 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside FibroBiologics's historical trend and sector peers before judging valuation or financial health.
Over the past year, FBLG's common stock moved from $0 to $1K. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in FibroBiologics's operating scale or balance-sheet position.
A common stock figure of $1K for FBLG is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.
After noting FBLG's common stock ($1K), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
